REFERENCES
- Adami G., Smarrelli D., Martinelli B., Acquavita A., Reisenhofer E.. 2003. Cobalt blood levels after total hip replacement (THR): A new follow-up study in Trieste (Italy).. Ann. Chim.. 93: 1–10. [PUBMED], [INFOTRIEVE]
- Barnes P. J.. 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma.. J. Allergy Clin. Immunol.. 83: 1013–1026. [PUBMED], [INFOTRIEVE]
- Barnes P. J.. 1998. New therapies for chronic obstructive pulmonary disease.. Thorax. 53: 137–147. [PUBMED], [INFOTRIEVE]
- Beatty K., Robertie P., Senior R. M., Travis J.. 1982. Determination of oxidized alpha-1-proteinase inhibitor in serum.. J. Lab. Clin. Med.. 100: 186–192. [PUBMED], [INFOTRIEVE]
- Brock T., Stopford W.. 2003. Bioaccessibility of metals in human health risk assessment: Evaluating risk from exposure to cobalt compounds.. J. Environ. Monit.. 5: 71N–76N. [PUBMED], [INFOTRIEVE]
- Christensen J. M., Poulsen O. M.. 1994. A 1982–1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes.. Sci. Total. Environ.. 150: 201–207
- Das S., Punniyamurthy T.. 2003. Cobalt (II)-catalyzed oxidation of alcohols into carboxylic acids and ketones with hydrogen peroxide.. Tetrahedron Lett.. 44: 6033–6035
- Dick C. A., J., Brown D. M., Donaldson K., Stone V.. 2003. The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types.. Inhal. Toxicol.. 15: 39–52. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Douwes J., Gibson P., Pekkanen J., Pearce N.. 2002. Non-eosinophilic asthma: Importance and possible mechanisms.. Thorax. 57: 643–648. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ejnik J., Robinson J., Zhu J. Y., Fosterling H., Shaw C. F., Petering D. H.. 2002. Folding pathway of apo-metallothionein induced by Zn2+, Cd2+ and Co2+.. J. Inorg. Biochem.. 88: 144–152. [PUBMED], [INFOTRIEVE]
- El-Hag A., Lipsky P. E., Bennett M., Clark R. A.. 1987. Immuno-modulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions.. J. Immunol.. 139: 1406–2413
- Feldman C., Anderson R., Kanthakumar K., Vargas A., Cole P. J., Wilson R.. 1994. Oxidant-mediated ciliary dysfunction in human respiratory epithelium.. Free Radical. Biol. Med.. 17: 1–10
- Greene C., Taggart C., Lowe G., Gallagher P., McElvaney N., O'Neill S.. 2003. Local impairment of anti-neutrophil elastase in community acquired pneumonia.. J. Infect. Dis.. 188: 769–776. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Hiemstra P. S.. 2002. Novel roles of protease inhibitors in infection and inflammation.. Biochem. Soc. Trans.. 30: 116–120. [PUBMED], [INFOTRIEVE]
- Holmsen H. E., Storm E., Day H. J.. 1972. Determination of ATP and ADP in blood platelets: A modification of the firefly luciferase assay for plasma.. Anal. Biochem.. 46: 481–502
- Lauwerys R., Lison D.. 1994. Health risks associated with cobalt exposure – An overview.. Sci. Total Environ.. 150: 1–6. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lehr H.-A., Frei B., Arfors K. E.. 1993. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to vascular endothelium.. Proc. Natl. Acad. Sci. USA. 91: 7688–7692
- Lieberman J.. 2000. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency—A new hypothesis with supporting data.. Chest. 118: 1480–1485. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Lim Y. P., Bendelja K., Opal S. M., Siryaporn E., Hixson D. C., Palardy J. E.. 2003. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis.. J. Infect. Dis.. 188: 919–926. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Linna A., Oksa P., Palmroos P., Roto P., Laippala P., Uitti J.. 2003. Respiratory health of cobalt production workers.. Am. J. Ind. Med.. 44: 124–132. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Morage F., Janciauskiene S.. 2000. Activation of primary human monocytes by the oxidized form of α1-antitrypsin.. J. Biol. Chem.. 275: 7693–7700
- Nemery B., Lewis C. P., L., Demedts M.. 1994. Cobalt and possible oxidant-mediated injury.. Sci. Total Environ.. 150: 57–64. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Nuorti J. P., Butler J. C., Farley M. M., Harrison L. H., McGreer A., Kolczak M. S., Breiman R. F.. 2000. Cigarette smoking and invasive pneumococcal disease.. N. Engl. J. Med.. 342: 681–689. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Richards G. A., Theron A. J., Van der Merwe C. A., Anderson R.. 1989. Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes.. Am. Rev. Respir. Dis.. 139: 181–187. [PUBMED], [INFOTRIEVE]
- Shapiro L., Pott G. B., Ralston A. H.. 2001. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.. FASEB J.. 15: 115–122. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Stockley R. A., Shaw J., Afford S. C., Morrison H. M., Burnett D.. 1990. Effects of alpha-1-proteinase inhibitor on neutrophil chemotaxis.. Am. J. Respir. Cell Mol. Biol.. 2: 163–170. [PUBMED], [INFOTRIEVE]
- Stockley R. A., Bayley D. L., Unsal I., Dowson L. J.. 2002. The effect of augmentation therapy on bronchial inflammation in alpha-1-antitrypsin deficiency.. Am. J. Respir. Crit. Care Med.. 165: 1494–1498. [CROSSREF], [PUBMED], [INFOTRIEVE]
- Swennen B., Buchet J.-P., Stanescu D., Lison D., Lauwerys R.. 1993. Epidemiological survey of workers exposed to cobalt oxides, cobalt salts, and cobalt metal.. Br. J. Ind. Med.. 50: 835–842. [PUBMED], [INFOTRIEVE]
- Weiss S. J.. 1989. Tissue destruction by neutrophils.. N. Engl. J. Med.. 320: 365–376. [PUBMED], [INFOTRIEVE]
- Weitzman S. A., Gordon L. I.. 1990. Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis.. Blood. 76: 655–663. [PUBMED], [INFOTRIEVE]
- Woolhouse I. S., Bayley D. L., Stockley R. A.. 2002. Sputum chemotactic activity in chronic obstructive pulmonary disease: Effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8.. Thorax. 57: 709–714. [PUBMED], [INFOTRIEVE]
- Wright J. L., Farmer S. G., Churg A.. 2003. A neutrophil elastase inhibitor reduces cigarette smoke-induced remodelling of lung vessels.. Eur. Respir. J.. 22: 77–81. [CROSSREF], [PUBMED], [INFOTRIEVE]